Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy

Area of Science:

• Pharmaceutical Nanotechnology
• Natural Product Chemistry
• Drug Delivery Systems

Background:

• Natural bioactive compounds offer therapeutic potential but face limitations like poor solubility and bioavailability.
• Traditional drug delivery methods struggle to overcome these challenges for natural compounds.
• Advancements in nanotechnology offer solutions for improving the pharmaceutical applications of these compounds.

Purpose of the Study:

• To review the application of nanotechnology, specifically lipid-based systems, for enhancing natural bioactive compounds.
• To highlight how nanotechnology overcomes limitations of natural compounds in drug delivery.
• To discuss the evaluation and clinical considerations of these nanotechnology-enabled compounds.

Main Methods:

• Review of scientific literature on nanotechnology-based drug delivery systems for natural bioactive compounds.
• Focus on lipid-based nanoparticles (LBNPs) as a delivery vehicle.
• Analysis of various bioactive compounds including paclitaxel, curcumin, and resveratrol.

Main Results:

• Lipid-based nanotechnologies demonstrate effective entrapment, stability, and controlled release of bioactive compounds.
• Nanotechnology significantly improves bioavailability and pharmacokinetic profiles.
• Enhanced therapeutic activity and reduced side effects are observed with nanotechnology-based delivery.

Conclusions:

• Nanotechnology, particularly lipid-based systems, offers a promising approach to overcome the limitations of natural bioactive compounds.
• These advanced delivery systems hold significant potential for improved clinical value and therapeutic efficacy.
• Further research and clinical evaluation are warranted for widespread adoption.